Disposal of International Brand Licensing AG

EKF Diagnostics Holdings plc (AIM: EKF), the growing in-vitro diagnostics company, announces that it has sold its Swiss subsidiary, International Brand Licensing AG (“IBL AG”) for a cash consideration of £50,000, payable over a 2 year period.

IBL AG was a legacy subsidiary which, following the completion of the sale of the rights of the Admiral sports brand by management in 2010, contained the Muscle Athletic sports brand.

Julian Baines, EKF’s CEO commented: "We are very pleased to have completed this disposal as it concludes the divestment from the sports licensing sector, allowing management to fully focus on further building our diagnostics business"

Back to Listing Previous Next

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

Trading update

The Company is pleased to announce that the trading in the second quarter of the year has continued the favourable trends experienced in the first quarter.

Notice of General Meeting

EKF Diagnostics announces that a general meeting of the Company will be held on 27^th July 2017.

Cancellation of share options

EKF Diagnostics announces that 21,614,766 share options over ordinary shares have been cancelled.

Result of AGM

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

Trading update

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, wishes to update shareholders on its current trading and the proposals it set out in its announcement on 20 March 2017.